Vildapin Plus Tablet 50 mg+850 mg combines Vildagliptin 50 mg and Metformin Hydrochloride 850 mg in a single oral formulation to manage type 2 diabetes mellitus effectively. This combination therapy is designed for patients whose blood glucose levels are not adequately controlled by diet, exercise, or monotherapy with either Vildagliptin or Metformin. By targeting different mechanisms of glucose regulation, Vildapin Plus helps achieve better glycemic control while minimizing the risk of hypoglycemia.

Vildagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, enhances the action of incretin hormones to stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner. Metformin, a biguanide, decreases hepatic glucose production and improves peripheral insulin sensitivity. Together, they provide a complementary approach to controlling both fasting and postprandial blood glucose levels.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

How Vildapin Plus Tablet Works

The combination of Vildagliptin and Metformin acts synergistically:

• Vildagliptin:

  • Inhibits the DPP-4 enzyme, increasing levels of active incretin hormones (GLP-1 and GIP)

  • Enhances glucose-dependent insulin secretion

  • Reduces glucagon secretion, lowering hepatic glucose output

• Metformin:

  • Suppresses hepatic gluconeogenesis, reducing fasting blood sugar

  • Improves insulin sensitivity in peripheral tissues

  • Increases glucose uptake by muscles and reduces intestinal glucose absorption

By addressing multiple pathways in glucose metabolism, Vildapin Plus 50 mg+850 mg provides effective and sustained blood sugar control.

Indications

Vildapin Plus Tablet 50 mg+850 mg is indicated for:

• Adults with type 2 diabetes mellitus inadequately controlled by diet and exercise alone

• Patients requiring combination therapy for better glycemic control

• Management of both fasting and postprandial hyperglycemia

• Use as first-line combination therapy in patients not achieving targets on monotherapy

It is suitable for adult patients seeking safe and effective long-term management of type 2 diabetes.

Dosage and Administration

• The usual recommended dose is one tablet twice daily, or as prescribed by a healthcare professional.

• Tablets should be taken with meals to reduce the risk of gastrointestinal side effects.

• Swallow the tablet whole with water; do not crush or chew.

• Regular monitoring of blood sugar levels is recommended to adjust the dosage as necessary.

Dose adjustments may be required for patients with renal or hepatic impairment. Adherence to diet, exercise, and prescribed therapy is crucial for optimal outcomes.

Precautions

• Use under medical supervision, especially in patients with kidney, liver, or heart conditions.

• Inform your doctor of all medications being taken to avoid potential drug interactions.

• Not suitable for type 1 diabetes or diabetic ketoacidosis.

• Pregnant or breastfeeding women should consult a healthcare professional before use.

• Avoid excessive alcohol intake, as Metformin may increase the risk of lactic acidosis.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Gastrointestinal discomfort such as nausea, diarrhea, or bloating

• Headache or dizziness

• Mild hypoglycemia, particularly when combined with other antidiabetic medications

• Nasopharyngitis or mild cold-like symptoms

Rare but serious side effects may include lactic acidosis, severe hypoglycemia, or liver enzyme elevation. Seek immediate medical attention if severe symptoms occur.

Storage

Store Vildapin Plus Tablet 50 mg+850 mg in a cool, dry place, protected from sunlight and moisture. Keep out of reach of children.

Vildapin Plus Tablet 50 mg+850 mg offers a powerful dual mechanism for managing type 2 diabetes, improving glycemic control, enhancing insulin response, and reducing long-term complications when used under proper medical supervision.